About
John Maraganore, Ph.D., is a biotech executive best known as the founding CEO of Alnylam Pharmaceuticals, which he led from 2002 until the 2021 leadership transition to Yvonne Greenstreet. He is now Co-Founder and Co-CEO of Corsera Health and holds investing roles including Executive Partner at RTW Investments and Advisor/Venture Partner roles with other life-sciences investment firms. His work centers on RNAi therapeutics, cardiovascular prevention, company creation, and biotech governance.
Areas of interest
biotechRNAi therapeuticscardiovascular diseasehealthspanpreventive medicinegenetic medicinesprecision medicineAI in healthoncologyimmunologyrare diseasecompany creation